Eric Hollander
Overview
Explore the profile of Eric Hollander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
238
Citations
7428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Snorrason I, Jaroszewski A, Greenberg J, Weingarden H, Summers B, Fang A, et al.
J Obsessive Compuls Relat Disord
. 2025 Jan;
42.
PMID: 39866242
The Yale-Brown Obsessive-Compulsive Scale modified for Body Dysmorphic Disorder (BDD-YBOCS) is a semi-structured interview designed to assess the severity of current BDD. The aim of the study was to examine...
2.
Josselsohn A, Zhao Y, Espinoza D, Hollander E
Pharmacol Ther
. 2024 Oct;
264:108734.
PMID: 39455012
This manuscript reviews recent work on oxytocin and its use in neurodevelopmental disorders including spectrum disorder (ASD) and Prader-Willi syndrome (PWS). Oxytocin is involved in social recognition, bonding, maternal behaviors,...
3.
Fineberg N, Stein D, Domschke K, Hollander E, Walitza S, Van Ameringen M, et al.
World Psychiatry
. 2024 Sep;
23(3):456-457.
PMID: 39279386
No abstract available.
4.
Pallanti S, Zohar J, Kasper S, Moller H, Hollander E
J Psychiatr Res
. 2023 Dec;
170:65-72.
PMID: 38103451
Since the mid 1980's, there has been an increased focus on the side effects of benzodiazepines (GABA enhancers), and as a result there has been a decrease in their use....
5.
Vismara M, Benatti B, Fineberg N, Hollander E, Van Ameringen M, Menchon J, et al.
CNS Spectr
. 2023 Sep;
29(1):40-48.
PMID: 37694338
Obsessive-compulsive disorder (OCD) is a prevalent and highly disabling condition, characterized by a range of phenotypic expressions, potentially associated with geo-cultural differences. This article aims to provide an overview of...
6.
Tobe R, Zhu Y, Gleissl T, Rossomanno S, Veenstra-VanderWeele J, Smith J, et al.
Neuropsychopharmacology
. 2023 Apr;
48(8):1201-1216.
PMID: 37045991
High rates of placebo response are increasingly implicated in failed autism spectrum disorder (ASD) clinical trials. Despite this, there are limited investigations of placebo response in ASD. We sought to...
7.
Taoulost S, Rasgon N, Ferretti C, Hollander E
J Psychiatr Res
. 2023 Mar;
161:307-309.
PMID: 36989905
No abstract available.
8.
Piccoli E, Hollander E
J Psychiatr Res
. 2022 Sep;
155:260-262.
PMID: 36116405
No abstract available.
9.
Fineberg N, Menchon J, Hall N, DellOsso B, Brand M, Potenza M, et al.
Compr Psychiatry
. 2022 Aug;
118:152346.
PMID: 36029549
Global concern about problematic usage of the internet (PUI), and its public health and societal costs, continues to grow, sharpened in focus under the privations of the COVID-19 pandemic. This...
10.
Bandelow B, Allgulander C, Baldwin D, Costa D, Denys D, Dilbaz N, et al.
World J Biol Psychiatry
. 2022 Jul;
24(2):118-134.
PMID: 35900217
Aim: This is the third version of the guideline of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic...